DNA Sequencing Helps Monitor Ocular Biome and Trachoma Potential
Quarterly oral azithromycin doses reduce ocular disease-causing bacteria, but enlarge macrolide resistance after 1 year.
Quarterly oral azithromycin doses reduce ocular disease-causing bacteria, but enlarge macrolide resistance after 1 year.
In a secondary data analysis, investigators sought to assess potential prescribing disparities for integrase strand transfer inhibitors in patients with HIV infection.
The COVID-19 pandemic has underscored a digital divide in healthcare, a report shows.